Philippe Brouqui, Didier Raoult, Jean Marc Durand

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Comparison of A60 and three glycolipid antigens in an ELISA test for tuberculosis Nancy Simonney, Jean Michel Molina, Mathieu Molimard, Eric Oksenhendler,

Philippe Erard, François Robert-Grandpierre, Pierre Kaeser

Ehrlichia canis and Leishmania infantum co-infection: a 3-year longitudinal study in naturally exposed dogs Y. Mekuzas, L. Gradoni, G. Oliva, V. Foglia.

Approach to diagnosis of infective endocarditis

Herpes zoster in non-hospitalized children

Atypical respiratory pathogens

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Immunoenzymatic dot-blot test for the diagnosis of enteric fever caused by Salmonella typhi in an endemic area Nora Cardona-Castro, Piedad Agudelo-Flórez

Use of antimicrobials and resistance in bacteria isolated from blood cultures in a Danish county from 1992 to 1995 Thomas Lund S⊘rensen, Niels Frimodt-M⊘ller,

Hydatid disease Clinical Microbiology and Infection

Successful treatment of Salmonella aortitis with ciprofloxacin

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

F. Rodríguez-Gómez, O. Cuevas, J. Anguita, P. Muñoz

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species Jacques Dubois, Claude St-Pierre Clinical.

Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente

S. Richard, P. Seng, P. Parola, D. Raoult, B. Davoust, P. Brouqui

Structure of grepafloxacin relative to activity and safety profile

Vector control: a cornerstone in the malaria elimination campaign

Fourth-generation cephalosporins: a review of in vitro activity, pharmacokinetics, pharmacodynamics and clinical utility Javier Garau, Walter Wilson,

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

Sofie Arens, Jan Verhaegen, Ludo Verbist

Multicenter study of the in vitro activity of cefepime in comparison with five other broad- spectrum antibiotics against clinical isolates of Gram-positive.

Training for the infectious diseases speciality in Norway

Cephalosporins: a pharmacological update

P. Seng, J.M. Rolain, D. Raoult, P. Brouqui

Epidemiology of opportunistic infections in AIDS patients

Laboratory diagnosis and biosafety issues of biological warfare agents

CMI editorial report 2011 Clinical Microbiology and Infection

Sepsis and neutropenia induced by clozapine

M. Or, M. Samish, T. Waner, S. Harrus

Uncommon opportunistic fungi: new nosocomial threats

H.K. Johansen, K. Kjeldsen, N. Høiby

Effect of antioxidants on the immune response of Helicobacter pylori

High serum neopterin and low cytokine values may indicate a non-bacterial etiology for fever of unknown origin in neutropenic patients Per Engervall,

Erythromycin susceptibility of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin King A. , Bathgate.

Laboratory diagnosis of Clostridium difficile disease

W.A. Craig Clinical Microbiology and Infection

Rickettsia felis and Rickettsia massiliae in Ivory Coast, Africa

Interactions between cytomegalovirus and the p53 tumor suppressor gene in atherosclerotic vascular disease Inge O. Baas, G. Johan A. Offerhaus, Ralph.

A. Bryskier Clinical Microbiology and Infection

Community-acquired pneumonia: epidemiologic and clinical consideration

Abstracts cont. Clinical Microbiology and Infection

Andrew M. Middleton, Maureen V. Chadwick, Harold Gaya

Clinical infection services—the Leiden experience

Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia M.-S. Hsu,

Molecular identification of Acinetobacter sp

Karine Ryffel, Olivier Péter, Luc Binet, Eric Dayer

An after-hours clinical liaison blood culture service—is it worth it?

European guidelines for diagnosis and management of patients with suspected herpes simplex encephalitis Miles Denton, Kevin G Kerr, Fraser Lewis Clinical.

Clinical Microbiology and Infection

Detection of IgA and low-avidity IgG antibodies for the diagnosis of recent active toxoplasmosis José Gutiérrez, María Rodríguez, Gonzalo Piédrola, María.

Overview of cefixime use in community-acquired infections

The first clinical isolate of Enterococcus faecium with the VanB phenotype in a teaching hospital in Greece J. Papaparaskevas, J. Stefanou, A. Vatopoulos,

Multiplexed whole bacterial antigen microarray, a new format for the automation of serodiagnosis: the culture-negative endocarditis paradigm F. Gouriet,

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

New oral cephalosporins in pediatric community-acquired infections

Javier Aznar, Hassan Safi, Maria C. Conejo, José C. Palomares

Clinical microbiological case: thermointolerant microorganism growth in blood cultures and catheter tip M. Blasco-Navalpotro, M. Jordán, J.J. Camarena,

Three years experience of real-time PCR for the diagnosis of Q fever

J.A. Pérez-Molina, F. Fernández Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

J. Esteban, A. Molleja, F. Cabria, M. Soledad Jimenez

Localized Mycobacterium avium complex infection in a patient on HAART

The future of diagnostic bacteriology

Vincent Calvez, Marc Grandadam Clinical Microbiology and Infection

Presentation transcript:

Ehrlichia species as possible causative agents of blood culture-negative endocarditis Philippe Brouqui, Didier Raoult, Jean Marc Durand Clinical Microbiology and Infection Volume 1, Issue 2, Pages 148-150 (December 1995) DOI: 10.1111/j.1469-0691.1995.tb00462.x Copyright © 1995 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Protein immunoblot analysis of our patient's serum collected in 1987. Line 1: E. chaffeensis antigen; line 2: E. canis antigen; A: serum from E. chaffeensis-infected mice; B: serum from E. chaffeensis-infected patient; C: normal human serum; D: patient's serum; Mw: approximate molecular weight (kDa). Note the presence of the low molecular mass proteins labelled by our patient's serum on the E. chaffeensis antigen. Clinical Microbiology and Infection 1995 1, 148-150DOI: (10.1111/j.1469-0691.1995.tb00462.x) Copyright © 1995 European Society of Clinical Infectious Diseases Terms and Conditions